Search

Context: Cardiovascular diseases claim the lives of an estimated 17.9 million people worldwide (report by the World Health Organization), yet the drug pipeline compared to some other life-threatening diseases, including cancer and neurological disorders, is low. Aims: To investigate the potential of Andrographis paniculata as a supplementary therapy for cardiovascular diseases based on recent in vivo animal studies. Methods: This study adopted a systematic review approach to analyze preclinical evidence from in vivo animal studies. Three databases (PubMed, Scopus, and Embase) were searched using the keywords “Andrographis paniculata”, “cardiovascular disease”, “CVD”, “heart disease”, “cardioprotective”, “cardio*”, “inflammation”, “oxidative stress”, “obesity”, “lipopolysaccharide”, “hypertension”, “arrhythmia” and “aortic disease”. The search period was from April 20th, 2023, to April 26th, 2023, and included studies published from 2013 to 2023. Only in vivo animal studies were appraised. In contrast, clinical studies, in vitro studies, in silico studies, and review papers were excluded. SYRCLE’s risk of bias tool was used to assess the risk of bias. Results: Sixteen eligible in vivo animal studies showed that Andrographis paniculata extracts and isolated bioactive compounds have strong anti-inflammatory and antioxidant effects on cardiovascular diseases. These effects lead to lowering the risk of coronary artery disease and myocardial infarction, easing the effects of bad cardiac remodeling, stopping cardiac hypertrophy, and improving diabetic cardiomyopathy. Although SYRCLE's tool detected some bias, the studies were included since they met the inclusion criteria and had no conflicts of interest. Conclusions: Andrographis paniculata may have the potential to be used as a supplementary therapy for cardiovascular diseases, but more animal studies and clinical trials should be done to establish these findings.

Context: Stem cell research has become popular in Indonesia for more than a decade. The scope of research involves in vitro to animal studies as well as human trials. However, no evidence proved its trend. Aims: To analyze the trends and patterns of stem cell research in Indonesia from 2003 to 2022 using a bibliometric analysis of the Scopus database. Methods: The data for the paper were retrieved from Scopus and then analyzed using bibliometrics. Statistical data analysis was performed. Results: The results showed that stem cell research in Indonesia has been increasing steadily over the years, with the majority of publications focusing on “Medicine”, “Biochemistry, Genetics, and Molecular Biology” and “Pharmacology, Toxicology, and Pharmaceutics”. It was found that a total of 260 related articles had been published. Rantam was identified as the most productive author, and the authorship network analysis identified nine clusters of authors. The keywords “stem cells”, “culture”, “proliferation”, “differentiation”, and “tissue engineering” were the most frequently used in the publications analyzed. Conclusions: Overall, this study provides valuable insights into the development of stem cell research in Indonesia and may inform future research and funding decisions in this field.